Navigation Links
Research Leads to First Treatment for Drug-Resistant HIV

more easily absorbed and tolerated by the body, according to research results.

"In Phase 3 clinical trials of TMC-114, the majority of patients receiving the drug did very well with relatively few side effects," Mitsuya said. "Those patients showed a significant increase in their CD4 cell counts. Many of those patients have been treated for a year or more and have shown no signs of developing a significant resistance to the drug."

Ghosh is now expanding on his design, making alterations to the original molecule aimed at making even more effective treatments.

"The most recent protease inhibitors we created are exceedingly potent," he said.

Ghosh's work has opened the door to a new path for antiretroviral therapy.

"Earlier, researchers were unsure of how to deal with drug-resistant viruses," he said. "Problems that arose with treatments developed in the 1990s were disheartening. There was no concept on the horizon. We created a conceptually new class of protease inhibitors to combat drug resistance. That has renewed excitement in antiretroviral treatment and provided a direction for the future."

These new protease inhibitors are beneficial for reasons beyond their potency and enduring effectiveness, Ghosh said.

"Because they are synthetic, lab-created materials, they are amenable to cost-effective mass production. Keeping costs down greatly increases the accessibility of the drugs to Third World countries where the epidemic is worst."

The design, synthesis and evaluation of these new protease inhibitors will be detailed in a paper in the Aug. 24 issue of the Journal of Medicinal Chemistry and is currently available on the journal's Web site.

Irene Weber of Georgia State University, Eric Walters of Rosalind Franklin University of Medicine and Mitsuya co-authored the papers with Ghosh. Mitsuya characterized the molecules' effectiveness and Walters and Weber perfor
'"/>




Page: 1 2 3 4

Related medicine news :

1. Kidney Stones - Interesting New Research implicates bacteria as its cause
2. Researchers urge caution in using ear tube surgery
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Researchers Scale to assess the Severity of Epilepsy in Kids
5. Research of Ritalin
6. Researchers trick Alzheimers Enzyme
7. Researchers find new HIV hiding place
8. A Compilation of recent Diabetes Research articles
9. Research on causes for falling helps develop preventive strategies
10. New standards for Human Research Safety
11. Research on Celiac Disease in children
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Research Leads First Treatment for Drug Resistant HIV

(Date:9/3/2015)... ... 03, 2015 , ... Leading post-acute electronic medical record (EMR) ... joining the company’s executive leadership team as VP of Product and as VP ... healthcare product and project management. He has been with HealthWyse since 2000 in ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... channels and efficient customer and technical support services to promote LodonalTM in Nigeria. ... Bridging trial evaluating the efficacy and safety of the product. , Managing Director, ...
(Date:9/2/2015)... ... September 03, 2015 , ... The Aspen Clinic ... - two retreats geared towards kick-starting and inspiring wellness in the Roaring Fork Valley ... part of developing a whole mind-body approach to fitness - we are much more ...
(Date:9/2/2015)... ... September 03, 2015 , ... One can hardly argue against the fact ... do laptops and personal computers. These devices are being used as GPS, to make ... of mobile dating apps, STD positive singles can now join the prestigious social ranks ...
(Date:9/2/2015)... ... September 03, 2015 , ... Each year, the editors ... public servants, activists, corporate executives, entrepreneurs, health care professionals, and others have had ... led the magazine to tap the National League for Nursing’s outspoken CEO, ...
Breaking Medicine News(10 mins):Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 2Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 3Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3
... ... in Italy, in conjunction with a team of doctors from the ... confirming that Pecorino Romano Cheese contains high amounts of CLA (Conjugated ... food groups. The study reveals that even in small amounts, ...
... Yummy commercial food smells contain noxious gases, researchers say ... aromas that restaurants emit are actually a type of ... health and the environment, U.S. researchers report. , Gases ... out by commercial food cooking, according to Deborah Gross, ...
... ... for your interview. One Portland, Oregon business is providing support—literally—for today’s job seekers. ... (PRWEB) March 24, ... ), today announced a special discount offer for those seeking employment and looking for ...
... ... a healthcare consulting firm, launches new corporate website with enhanced content, navigation and performance. ... ... consulting services for the healthcare industry, is pleased to announce that it has launched ...
... ... and with celebrity appeal, generating success in a difficult economy. , ... (PRWEB) March 24, 2010 -- The ... celebrities., , ,Leeza Gibbons, popular entertainment personality and National Spokesperson for ZERONA, has proven ...
... ... asks that you join in recognizing all physicians on National Doctor,s Day, March 30 -- ... ... March 30 is National Doctor’s Day. The American Board of Physician Specialties (ABPS) ...
Cached Medicine News:Health News:Say Cheese! New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:What's Cookin'? It Could Be Air Pollution 2Health News:Your Posture Can Make or Break Your Job Interview; PostureNOW Offers 33% Off Its Posture Corrective Brace to Job Seekers Nationwide 2Health News:Leading Healthcare Human Resource Consulting Firm, Integrated Healthcare Strategies, Launches New Website 2Health News:Leading Healthcare Human Resource Consulting Firm, Integrated Healthcare Strategies, Launches New Website 3Health News:Leeza Gibbons and ZERONA Equals a Winning Combination 2Health News:American Board of Physician Specialties (ABPS) Celebrates Doctor's Day 2010 2
(Date:9/2/2015)... Sept. 2, 2015  Seeger Weiss LLP is reporting ... will commence October 13, 2015. Since ... fast-track approval program, Zimmer NexGen knee implant surpassed FDA ... that companies provide evidence that the product is substantially ... to gain permissions. In 2001, Zimmer ...
(Date:9/2/2015)... Sept. 2, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... Chief Financial Officer of Neurocrine Biosciences, will be presenting ... New York City . The live ... ET (8:25am PT).  The presentation will be webcast and ... http://www.neurocrine.com .   Listeners are encouraged to ...
(Date:9/2/2015)... -- Demers Ambulances is proud to announce it has signed ... the states of Mississippi , ... "This will enable Demers to effectively meet the ... Vice-President for Demers Ambulances. "Emergency Equipment Professionals has three service ... Alabama , giving them a strategic advantage. Local ...
Breaking Medicine Technology:Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2Demers Ambulances has named Emergency Equipment Professionals (EEP) Inc. as their dealer for the states of MS, AL and TN 2
... call Monday, March 10, 2008 at 8:30am, NEW ... ) today announced top-line results from its SUN-MICRO,Phase 3 ... nephropathy. The Company announced that this Phase 3 clinical,trial ... which was to,increase the proportion of patients that achieve ...
... Hardening Affects of the,Devastating Disease, CHICAGO, March ... the effects of an anti-cancer drug to treat,patients ... leads to hardening and tightening of the skin ... in the United States and,can often attack the ...
Cached Medicine Technology:Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 2Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 3Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint 4Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients 2
6 inch hand held occlcuder with 49 holes...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Manual Lensmeter....
Lightweight, cordless lensmeter....
Medicine Products: